Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
出版年份 2019 全文链接
标题
Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 294, Issue 41, Pages 15137-15157
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2019-08-30
DOI
10.1074/jbc.rev119.006901
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors
- (2019) Kevin M. Peese et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors
- (2019) Tyler A. Wilson et al. ACS Medicinal Chemistry Letters
- Challenges and opportunities in cryo-EM single-particle analysis
- (2019) Dmitry Lyumkis JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of Neural Tube Defects (NTD) After Exposure to Raltegravir During Pregnancy
- (2019) Hala Shamsuddin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Is there a safety signal for dolutegravir and integrase inhibitors during pregnancy?
- (2019) Laurent Chouchana et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir
- (2019) Vani Vannappagari et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle
- (2019) Rachel Van Duyne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
- (2019) Pratibha C Koneru et al. eLife
- A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study
- (2019) Subhra Mandal et al. ANTIVIRAL RESEARCH
- Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
- (2019) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
- (2019) Jessica Radzio-Basu et al. Nature Communications
- Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies
- (2019) Michael Aboud et al. Lancet HIV
- HIV-1 integrase inhibitors that are broadly effective against drug-resistant mutants
- (2018) Steven J. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor
- (2018) B. Narasimhulu Naidu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cellular and molecular mechanisms of HIV-1 integration targeting
- (2018) Alan N. Engelman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial
- (2018) Jose L Blanco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration
- (2018) Damien Bonnard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy
- (2018) Ingeborg E A Wijting et al. JOURNAL OF INFECTIOUS DISEASES
- Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors
- (2018) Wendy W Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Changes to dolutegravir policy in several African countries
- (2018) Esther Nakkazi LANCET
- Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane
- (2018) Zheng Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitors of the integrase–transportin-SR2 interaction block HIV nuclear import
- (2018) Jonas Demeulemeester et al. Retrovirology
- Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
- (2018) Steven J. Smith et al. Retrovirology
- How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir
- (2018) Atze T. Das et al. mBio
- Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
- (2018) Isabelle Malet et al. mBio
- Creation of a long-acting nanoformulated dolutegravir
- (2018) Brady Sillman et al. Nature Communications
- Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
- (2018) Rebecca Zash et al. Lancet Global Health
- Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration
- (2018) Vasudevan Achuthan et al. Cell Host & Microbe
- Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import
- (2018) Kylie M. Wagstaff et al. CELLULAR MICROBIOLOGY
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase
- (2018) Sibes Bera et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
- (2018) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection
- (2018) Zeger Debyser et al. Viruses-Basel
- Visualization of biological macromolecules at near-atomic resolution: cryo-electron microscopy comes of age
- (2018) Alok K. Mitra Acta Crystallographica Section F-Structural Biology Communications
- Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing
- (2017) Ashley C. Hoyte et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A C-terminal “Tail” Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly
- (2017) Krishan K. Pandey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
- (2017) Xue Zhi Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells
- (2017) Michaela K. Madison et al. JOURNAL OF VIROLOGY
- The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity
- (2017) Céline Amadori et al. Retrovirology
- Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome
- (2017) Dario Oliveira Passos et al. SCIENCE
- A supramolecular assembly mediates lentiviral DNA integration
- (2017) Allison Ballandras-Colas et al. SCIENCE
- Capsid-Dependent Host Factors in HIV-1 Infection
- (2017) Masahiro Yamashita et al. TRENDS IN MICROBIOLOGY
- Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
- (2017) Isabelle Malet et al. mBio
- Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration
- (2017) E. Fabian Cardozo et al. PLoS Pathogens
- Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial
- (2017) Ingeborg Wijting et al. Lancet HIV
- The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency
- (2016) Lei Feng et al. ACS Chemical Biology
- HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases
- (2016) Xue Zhi Zhao et al. ACS Chemical Biology
- Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile
- (2016) Manuel Tsiang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results
- (2016) Celia Oldenbuettel et al. ANTIVIRAL THERAPY
- HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis
- (2016) Jacques J. Kessl et al. CELL
- What Integration Sites Tell Us about HIV Persistence
- (2016) Stephen H. Hughes et al. Cell Host & Microbe
- Retroviral DNA Integration
- (2016) Paul Lesbats et al. CHEMICAL REVIEWS
- Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression
- (2016) Jhon Rojas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia
- (2016) C. Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Crystal structure of the Rous sarcoma virus intasome
- (2016) Zhiqi Yin et al. NATURE
- Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function
- (2016) Allison Ballandras-Colas et al. NATURE
- DNA minicircles clarify the specific role of DNA structure on retroviral integration
- (2016) Marco Pasi et al. NUCLEIC ACIDS RESEARCH
- A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin
- (2016) Gregory A. Sowd et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies
- (2016) Nanjie Deng et al. PROTEIN SCIENCE
- Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs
- (2016) Lee D. Fader et al. ACS Medicinal Chemistry Letters
- Current status and prospects of HIV treatment
- (2016) Tomas Cihlar et al. Current Opinion in Virology
- Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase
- (2016) Kushol Gupta et al. PLOS BIOLOGY
- LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
- (2016) Lenard S. Vranckx et al. EBioMedicine
- The Integrase Cofactor LEDGF/p75 Associates with Iws1 and Spt6 for Postintegration Silencing of HIV-1 Gene Expression in Latently Infected Cells
- (2015) Annabelle Gérard et al. Cell Host & Microbe
- LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes
- (2015) Parmit Kumar Singh et al. GENES & DEVELOPMENT
- Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors
- (2015) Izzat T. Raheem et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation
- (2015) Juan Fontana et al. JOURNAL OF VIROLOGY
- Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication
- (2015) Shewit S. Tekeste et al. JOURNAL OF VIROLOGY
- Structural basis for retroviral integration into nucleosomes
- (2015) Daniel P. Maskell et al. NATURE
- The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge
- (2015) J. Radzio et al. Science Translational Medicine
- A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge
- (2015) Chasity D. Andrews et al. Science Translational Medicine
- Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
- (2014) Craig Fenwick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)
- (2014) Jonas Demeulemeester et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Allosteric Inhibition of Human Immunodeficiency Virus Integrase
- (2014) Kushol Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The HIV-1 Integrase Mutant R263A/K264A Is 2-fold Defective for TRN-SR2 Binding and Viral Nuclear Import
- (2014) Stéphanie De Houwer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism
- (2014) H. J. Fadel et al. JOURNAL OF VIROLOGY
- Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding
- (2014) Erik Serrao et al. NUCLEIC ACIDS RESEARCH
- Engineered Hyperactive Integrase for Concerted HIV-1 DNA Integration
- (2014) Min Li et al. PLoS One
- Structural basis for nuclear import of splicing factors by human Transportin 3
- (2014) G. N. Maertens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase
- (2014) Alison Slaughter et al. Retrovirology
- Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus
- (2014) C. D. Andrews et al. SCIENCE
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
- (2014) T. A. Wagner et al. SCIENCE
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
- (2014) Lee D. Fader et al. ACS Medicinal Chemistry Letters
- Highly Active Antiretroviral Therapies Are Effective against HIV-1 Cell-to-Cell Transmission
- (2014) Luis M. Agosto et al. PLoS Pathogens
- A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
- (2014) Amit Sharma et al. PLoS Pathogens
- Testing the Substrate-Envelope Hypothesis with Designed Pairs of Compounds
- (2013) Yang Shen et al. ACS Chemical Biology
- Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir
- (2013) Wei Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
- (2013) Lei Feng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
- (2013) S. Alireza Rabi et al. JOURNAL OF CLINICAL INVESTIGATION
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- (2013) François Raffi et al. LANCET INFECTIOUS DISEASES
- Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
- (2013) Jocelyn O. Eidahl et al. NUCLEIC ACIDS RESEARCH
- Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells
- (2013) Mini Balakrishnan et al. PLoS One
- Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics
- (2013) Felix DeAnda et al. PLoS One
- Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation
- (2013) K. A. Jurado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
- (2013) Belete Desimmie et al. Retrovirology
- Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage
- (2013) Erwann Le Rouzic et al. Retrovirology
- Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
- (2013) Soundasse Munir et al. Retrovirology
- Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain
- (2013) Rick van Nuland et al. Epigenetics & Chromatin
- HIV-1 Assembly, Budding, and Maturation
- (2013) W. I. Sundquist et al. Cold Spring Harbor Perspectives in Medicine
- HIV-1 Antiretroviral Drug Therapy
- (2013) E. J. Arts et al. Cold Spring Harbor Perspectives in Medicine
- 24 Hours in the Life of HIV-1 in a T Cell Line
- (2013) Pejman Mohammadi et al. PLoS Pathogens
- Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization
- (2012) Frauke Christ et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 3′-Processing and strand transfer catalysed by retroviral integrasein crystallo
- (2012) Stephen Hare et al. EMBO JOURNAL
- New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
- (2012) Manuel Tsiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
- (2012) Jacques J. Kessl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor
- (2012) Hao Wang et al. NUCLEIC ACIDS RESEARCH
- Assembly of prototype foamy virus strand transfer complexes on product DNA bypassing catalysis of integration
- (2012) Zhiqi Yin et al. PROTEIN SCIENCE
- Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing
- (2012) Madapura M. Pradeepa et al. PLoS Genetics
- LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs
- (2012) Rik Schrijvers et al. PLoS Pathogens
- Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143
- (2011) Mathieu Métifiot et al. AIDS
- Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes
- (2011) Kendra E. Hightower et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The HIV-1 Integrase Monomer Induces a Specific Interaction with LTR DNA for Concerted Integration
- (2011) Krishan K. Pandey et al. BIOCHEMISTRY
- Dithiothreitol Causes HIV-1 Integrase Dimer Dissociation While Agents Interacting With the Integrase Dimer Interface Promote Dimer Formation
- (2011) Manuel Tsiang et al. BIOCHEMISTRY
- Identification of Critical Motifs within HIV-1 Integrase Required for Importin α3 Interaction and Viral cDNA Nuclear Import
- (2011) Kallesh Danappa Jayappa et al. JOURNAL OF MOLECULAR BIOLOGY
- LEDGF Dominant Interference Proteins Demonstrate Prenuclear Exposure of HIV-1 Integrase and Synergize with LEDGF Depletion To Destroy Viral Infectivity
- (2011) A. M. Meehan et al. JOURNAL OF VIROLOGY
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
- (2011) Y. Koh et al. JOURNAL OF VIROLOGY
- Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
- (2011) S. Hare et al. MOLECULAR PHARMACOLOGY
- Global landscape of HIV–human protein complexes
- (2011) Stefanie Jäger et al. NATURE
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
- (2011) Alex Sigal et al. NATURE
- Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus
- (2011) Alberto De Iaco et al. Retrovirology
- Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import
- (2011) Alexandra Cribier et al. Retrovirology
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis
- (2010) Andrew J Buckton et al. ANTIVIRAL THERAPY
- Importin 3 Interacts with HIV-1 Integrase and Contributes to HIV-1 Nuclear Import and Replication
- (2010) Z. Ao et al. JOURNAL OF VIROLOGY
- Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core
- (2010) M. S. Briones et al. JOURNAL OF VIROLOGY
- Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs
- (2010) T. Paprotka et al. JOURNAL OF VIROLOGY
- Retroviral intasome assembly and inhibition of DNA strand transfer
- (2010) Stephen Hare et al. NATURE
- The mechanism of retroviral integration from X-ray structures of its key intermediates
- (2010) Goedele N. Maertens et al. NATURE
- Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
- (2010) Frauke Christ et al. Nature Chemical Biology
- Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
- (2010) S. Hare et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy
- (2010) Mark G Lewis et al. Retrovirology
- Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors
- (2010) Robert A Smith et al. Retrovirology
- Identification of cellular factors binding to acetylated HIV-1 integrase
- (2009) Awatef Allouch et al. AMINO ACIDS
- Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers
- (2009) S. Min et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
- (2009) A. Low et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
- (2009) Marie-Pierre de Béthune ANTIVIRAL RESEARCH
- Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
- (2009) Damian J. McColl et al. ANTIVIRAL RESEARCH
- Retroviral integrase superfamily: the structural perspective
- (2009) Marcin Nowotny EMBO REPORTS
- Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase
- (2009) Thomas A. Wilkinson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase
- (2009) L. Krishnan et al. JOURNAL OF VIROLOGY
- An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
- (2009) J. J. Kessl et al. MOLECULAR PHARMACOLOGY
- A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75
- (2009) Stephen Hare et al. PLoS Pathogens
- Structural Basis for Functional Tetramerization of Lentiviral Integrase
- (2009) Stephen Hare et al. PLoS Pathogens
- Quantitative analysis of the interactions between HIV-1 integrase and retroviral reverse transcriptases
- (2008) Alon Herschhorn et al. BIOCHEMICAL JOURNAL
- The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors
- (2008) David R. Langley et al. BIOCHEMISTRY
- The N-Terminal Basic Domain of the HIV-1 Matrix Protein Does Not Contain a Conventional Nuclear Localization Sequence But Is Required for DNA Binding and Protein Self-Association†
- (2008) Anna C. Hearps et al. BIOCHEMISTRY
- 10-Hydroxy-7,8-dihydropyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: Potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants
- (2008) Catherine M. Wiscount et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Three-Dimensional Analysis of Budding Sites and Released Virus Suggests a Revised Model for HIV-1 Morphogenesis
- (2008) Lars-Anders Carlson et al. Cell Host & Microbe
- Transportin-SR2 Imports HIV into the Nucleus
- (2008) Frauke Christ et al. CURRENT BIOLOGY
- HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro
- (2008) B. Roquebert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein
- (2008) Christopher J. McKee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases
- (2008) Isabelle Malet et al. JOURNAL OF MEDICAL VIROLOGY
- Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection
- (2008) Vincenzo Summa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Construction and infection of a new simian/human immunodeficiency chimeric virus (SHIV) containing the integrase gene of the human immunodeficiency virus type 1 genome and analysis of its adaptation to monkey cells
- (2008) Hisashi Akiyama et al. MICROBES AND INFECTION
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
- (2008) David A. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional and structural characterization of the integrase from the prototype foamy virus
- (2008) Eugene Valkov et al. NUCLEIC ACIDS RESEARCH
- Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
- (2008) Soo-Yon Rhee et al. Retrovirology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now